Update on Anti-Obesity Medications

//////////// SLIDER //////////// SLIDER //////////// SLIDER ////////////

Focused Learning Course on Anti-Obesity Medications. You’ll learn…

Obesity – Is it a disease?

To recognize that obesity is a treatable medical condition
To describe the spectrum of treatment options available for obesity
About the four pillars of obesity medicine

To understand the criteria and considerations for prescribing anti-obesity medications (AOMs)
To address and mitigate weight bias in clinical practice

Optimizing Chronic Medications

To identify common medications associated with weight changes
The principles of deprescribing to manage weight gain
To integrate pharmacological treatments within a comprehensive obesity management framework

To use knowledge of weight properties to optimize medications for weight management
To prescribe diabetes mellitus type 2 medications in an optimal manner for weight management

Anti-obesity Medications: Common Oral Agents

To recognize how to carefully select patients for anti-obesity medications
To confidently prescribe Bupropion/naltrexone (Contrave®)
To confidently prescribe Phentermine/topiramate (Qsymia®)

To describe approved and off-label uses of anti-obesity medications including regulations for duration of use
The principles of integrating pharmacologic treatments within a comprehensive obesity management framework

Anti-obesity Medications: GLP-1 Agonists

To confidently prescribe glucagon-like peptide-1 (GLP-1) receptor agonists and the dual GLP-1/GIP agonist
To effectively troubleshoot when prescribing from the GLP-1 agonist medication class

To recognize upcoming anti-obesity medications in the pipeline
About the comparative efficacy and safety profiles of GLP-1 agonists
About the clinical considerations and practical tips for prescribing GLP-1 agonists

Anti-obesity Medications: Other Agents

To describe rare genetic disorders of obesity and FDA-approved indications for setmelanotide and metreleptin
To understand the indications and procedures for prescribing Gelesis100 hydrogel

To counsel patients about medications that are not recommended to achieve weight loss
To summarize the long-term FDA-approved weight loss medications and their efficacy

Individualizing Obesity Pharmacotherapy

To manage obesity pharmacotherapy in patients with a history of substance abuse
To individualize obesity treatment for patients with underlying medical conditions

To understand obesity treatment barriers and how to advocate for patient access to treatment
To create individualized treatment plans and advocate for insurance coverage

^$149

100% Money Back Guarantee – See Terms & Conditions

Update on Anti-Obesity Medications for Creating Effective Treatment Plans

With the growing number of options on the market – more medications in more classes – this course helps you make the best possible treatment decisions. Patients these days enter your office both with more questions than ever and with more informed opinions after having done their own ‘research.’ Now you’ll be prepared with up-to-date details on the full range of medication options available in 2023. Increase your knowledge, make better decisions, and speed discussions with patients and writing of progress notes.

Topics Covered

Obesity as a Disease
Detailed Review of Anti-Obesity Medications
Cases & Review by Patient Category
Insurance Considerations

Course Benefits

All lectures available now
4 AMA PRA Category 1 CME Credits™ included
Course Syllabus pdf with all slide content
12-month access to course recordings

Update on Anti-Obesity Medications Course Agenda

Obesity – Is it a disease? – Laura Davisson, MD

To recognize that obesity is a treatable medical condition
To describe the spectrum of treatment options available for obesity
About the four pillars of obesity medicine
To understand the criteria and considerations for prescribing anti-obesity medications (AOMs)
To address and mitigate weight bias in clinical practice

Optimizing Chronic Medications – Laura Davisson, MD and Angela Goodhart, PharmD

To identify common medications associated with weight changes
To use knowledge of weight properties to optimize medications for weight management
To prescribe diabetes mellitus type 2 medications in an optimal manner for weight management
The principles of deprescribing to manage weight gain
To integrate pharmacological treatments within a comprehensive obesity management framework

Anti-obesity Medications: Common Oral Agents – Laura Davisson, MD and Angela Goodhart, PharmD

To recognize how to carefully select patients for anti-obesity medications
To confidently prescribe Bupropion/naltrexone (Contrave®)
To confidently prescribe Phentermine/topiramate (Qsymia®)
To describe approved and off-label uses of anti-obesity medications including regulations for duration of use
The principles of integrating pharmacologic treatments within a comprehensive obesity management framework

Anti-obesity Medications: GLP-1 Agonists – Laura Davisson, MD and Angela Goodhart, PharmD

To confidently prescribe glucagon-like peptide-1 (GLP-1) receptor agonists and the dual GLP-1/GIP agonist
To effectively troubleshoot when prescribing from the GLP-1 agonist medication class
To recognize upcoming anti-obesity medications in the pipeline
About the comparative efficacy and safety profiles of GLP-1 agonists
About the clinical considerations and practical tips for prescribing GLP-1 agonists

Anti-obesity Medications: Other Agents – Laura Davisson, MD and Angela Goodhart, PharmD

Understand the mechanism of action, FDA indications, dosing, common side effects, and clinical considerations for prescribing orlistat
To describe rare genetic disorders of obesity and FDA-approved indications for setmelanotide and metreleptin
To understand the indications and procedures for prescribing Gelesis100 hydrogel
To counsel patients about medications that are not recommended to achieve weight loss
To summarize the long-term FDA-approved weight loss medications and their efficacy

Individualizing Obesity Pharmacotherapy – Laura Davisson, MD

To individualize obesity treatment for patients with underlying medical conditions
To treat obesity in special populations, such as individuals who may get pregnant, elderly patients, and those who have had prior bariatric surgery, ensuring safe and effective weight management tailored to their unique needs
To understand obesity treatment barriers and how to advocate for patient access to treatment
To manage obesity pharmacotherapy in patients with a history of substance abuse
To create individualized treatment plans and advocate for insurance coverage

Learn to Support and Empower Your Patients with Appropriate Weight Loss Treatment

Weight management medications encompass a range of mechanisms to combat the challenges of excess weight. Some are designed to reduce hunger pangs and promote early satiety, enabling better portion control. Others help the body burn more calories by increasing metabolism. Still, others inhibit the body’s absorption of dietary fats, ultimately decreasing a person’s overall calorie consumption.

Which medications are right for each of your patients? This course will help you know.

The best obesity treatment for a particular patient will depend on their individual needs and circumstances. Some factors to consider include the patient’s age, weight, health history, and other medications they are taking.

Common weight loss medications covered in this course:

By staying informed about the latest advancements in weight management medications, you can help your patients achieve their weight loss goals and improve their overall health. Some of the most common anti-obesity medications for weight loss treatment covered in this course include:

Semaglutide (Wegovy): This medication is a newer once weekly injectable medication that works by mimicking a gut hormone that helps regulate appetite.

Liraglutide (Saxenda): This medication is a daily injectable medication that works by mimicking a gut hormone that helps regulate appetite.

Orlistat (Xenical, Alli): This medication works by blocking fat absorption from food.

Phentermine (Adipex-P): This medication is a stimulant that suppresses appetite.

Topiramate/phentermine (Qsymina): This medication combines two medications to suppress appetite.

Naltrexone/bupropion (Contrave): This medication combines two medications that work together to reduce hunger and increase energy expenditure.

Up-and-coming medications in the pipeline and off label use of medications to promote weight loss

Embrace the opportunity to significantly impact your patients’ health and well-being by learning about the treatment of obesity with anti-obesity medications.

Better Advocate for Your Patients with Our Updates on Anti-Obesity Medications Course

With our Updates on Anti-Obesity Medications course, you can unlock the potential of effective weight loss treatment with medications and guide your patients to live their best, healthiest lives. Enhance your ability to provide appropriate care and improve patient outcomes by garnering knowledge about the diverse medications for the treatment of overweight patients and those with obesity.

Save 20% through August 15, 2024!
Update on Anti-Obesity Medications	~~^$149~~ ^$149	Register Now

Update on Anti-Obesity Medications

Detailed, Practical Advice You Need to Create Patient-Specific Obesity Treatment Plans

Lightning Reviews are short, high-yield courses that get clinicians up to speed on need-to-know topics.

Focused Learning Course on Anti-Obesity Medications. You’ll learn…

Update on Anti-Obesity Medications